The FY2024 (Dec) proxy of Vertex Pharmaceuticals Inc / Ma names 12 peer companies for pay. Among Vertex Pharmaceuticals Inc / Ma and these peers, CEO pay was 5th highest of 9 and total shareholder return was 5th highest of 9.
5th highest of 9in Vertex Pharmaceuticals Inc / Ma and its pay peers, FY2024 (Dec) by CEO pay:
$6.8M$29.2M
5th highest of 9in Vertex Pharmaceuticals Inc / Ma and its pay peers, FY2024 (Dec) by total shareholder return:
$52$627
Pay peer group, FY2024 (Dec) proxy
| Eli Lilly & Co | ||
| Amgen | ||
| Biogen | ||
| Gilead Sciences | ||
| Bristol Myers Squibb | ||
| AbbVie | ||
| Incyte | ||
| Regeneron Pharmaceuticals | ||
| Alnylam Pharmaceuticals | Not disclosed | Not disclosed |
| BioMarin Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Jazz Pharmaceuticals plc | Not disclosed | Not disclosed |
| Moderna | Not disclosed | Not disclosed |
12 companies
Changes by year
FY2025 (Dec) proxy
- RemovedSeagen Inc.pay peer groupsince 2022, except for the removal of Seagen Inc. in 2024 due to its acquisition by
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.